Varian Medical Systems Inc
Change company Symbol lookup
Select an option...
VAR Varian Medical Systems Inc
ALK Alaska Air Group Inc
HSBC HSBC Holdings PLC
HFWA Heritage Financial Corp
SUI Sun Communities Inc
SON Sonoco Products Co
KALU Kaiser Aluminum Corp
RS Reliance Steel & Aluminum Co
HCSG Healthcare Services Group Inc
NURO NeuroMetrix Inc
Go

Health Care : Health Care Equipment & Supplies | Mid Cap Growth
Company profile

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, cardiac radioablation, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product. Through its subsidiary, Cooperative CL Enterprises, the Company distributes radiotherapy equipments in Taiwan.

Closing Price
$171.73
Day's Change
-0.13 (-0.08%)
Bid
--
Ask
--
B/A Size
--
Day's High
172.10
Day's Low
171.52
Volume
(Light)
Volume:
760,272

10-day average volume:
985,174
760,272

Display:

Providers:

UpdateCancel
6 providers
October 20, 2020
Varian Congratulates Historic Trade Package Agreement with Brazil

Varian (NYSE: VAR) congratulates the United States Trade Representative and the Ministry of Development, Industry and Foreign Trade of Brazil on achieving the first steps of a trade agreement focused on good regulatory practices, trade facilitation...(PR Newswire)

October 19, 2020
Varian Announces Presence at American Society for Radiation Oncology (ASTRO) Annual Meeting Highlighting Advancements in Intelligent Cancer Care(TM)

Varian (NYSE: VAR), a leading provider of cancer care technologies and solutions, continues to reinforce its commitment to delivering Intelligent Cancer Care(TM) during the 2020 American Society for Radiation Oncology (ASTRO) taking place virtually...(PR Newswire)

October 16, 2020
Varian Announces Fourth Quarter Fiscal Year 2020 Earnings Release Date

Varian (NYSE: VAR) today announced its fourth quarter of fiscal year 2020 earnings release date. The Company will report results for the fourth quarter of fiscal year 2020 after market close on Tuesday, October 27, 2020. (PR Newswire)

October 15, 2020
Varian Stockholders Approve Combination with Siemens Healthineers

Varian (NYSE: VAR) today announced that its stockholders have voted to approve the previously announced pending combination with Siemens Healthineers AG (Frankfurt: SHL) at a special meeting. Varian stockholders voted overwhelmingly in favor of the...(PR Newswire)

October 12, 2020
Varian Receives Investigational Device Exemption (IDE) and Prepares for First Ever Clinical Trial of FLASH Therapy

Varian (NYSE: VAR) today announced the company has received an Investigational Device Exemption (IDE) from the Food and Drug Administration (FDA) for the first-ever clinical trial of FLASH therapy, an experimental treatment modality delivering...(PR Newswire)

October 02, 2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds RST, GANS, and VAR Shareholders About Its Ongoing Investigations

https://mma.prnewswire.com/media/743985/WeissLaw_Logo_Stacked_LowerCase_color_2_Logo.jpg If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights...(PR Newswire)

Lifshitz Law Firm, P.C. Announces Investigation of BMC Stock Holdings, Inc. (NASDAQ:BMCH), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), and Varian Medical Systems, Inc. (NYSE: VAR)

BMC Stock Holdings, Inc. (NASDAQ:BMCH) - Builders FirstSource, Inc. (NASDAQ:BLDR) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of BMCH to Builders FirstSource, Inc. (Globe Newswire)

September 25, 2020
Lifshitz Law Firm, P.C. Announces Investigation of Livongo Health, Inc. (NASDAQ:LVGO), Varian Medical Systems, Inc. (NYSE: VAR) and Virtusa Corporation (NASDAQ: VRTU)

EQNX::TICKER_START (NYSE:VAR),(NASDAQ:LVGO),(NASDAQ:VRTU), EQNX::TICKER_END Livongo Health, Inc. (NASDAQ:LVGO) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of LVGO to Teladoc...(Globe Newswire)

September 23, 2020
Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Varian Medical Systems, Inc. (VAR)

Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Northern District of California, Case No. 4:20-cv-06266-YGR on behalf of shareholders of Varian Medical Systems, Inc...(Globe Newswire)

September 18, 2020
WeissLaw LLP Reminds JCAP and VAR Shareholders About Its Ongoing Investigations

https://mma.prnewswire.com/media/743985/WeissLaw_Logo_Stacked_LowerCase_color_2_Logo.jpg If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights...(PR Newswire)

September 16, 2020
Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Rosetta Stone, Momenta, Jernigan, and Varian on behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of Rosetta Stone Inc. (NYSE: RST), Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), Jernigan Capital, Inc. (NYSE: JCAP), and Varian...(Globe Newswire)

Lifshitz Law Firm, P.C. Announces Investigation of Immunomedics, Inc. (NASDAQ: IMMU), Livongo Health, Inc. (NASDAQ:LVGO), Varian Medical Systems, Inc. (NYSE: VAR) and Virtusa Corporation (NASDAQ: VRTU)

EQNX::TICKER_START (NasdaqGM:IMMU),(NASDAQ:LVGO),(NYSE:VAR),(NASDAQ:VRTU), EQNX::TICKER_END Immunomedics, Inc. (NASDAQ: IMMU) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of...(Globe Newswire)

Varian Expects to Benefit from the Extension of Medical Linear Accelerators Tariff Exclusion in China

Varian (NYSE: VAR) has received notice from the Customs Tariff Commission of the State Council of China that the first exclusion of the additional tariffs China imposed on US products will expire on September 16, 2020. In accordance with procedures...(PR Newswire)

September 15, 2020
Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1

Highlights: -- Integration of Dual Energy CT (DECT) images in the Eclipse planning process reduces range uncertainty and helps clinicians' spare healthy tissue. -- Graphics Processing Unit (GPU) accelerates the speed of Monte Carlo proton dose...(PR Newswire)

September 14, 2020
Varian Announces Appointment of Chris Toth as President and Chief Operating Officer

Varian (NYSE: VAR) today announced the following leadership appointments, effective October 5, 2020: -- Chris Toth, Varian Oncology Systems President, has been appointed to the newly created role of President and Chief Operating Officer; (PR Newswire)

September 10, 2020
Varian Announces Goshen Center for Cancer Care Treats First Patient with Ethos(R) Therapy, Expanding Access to Personalized Cancer Care

Varian (NYSE: VAR) today announced the Goshen Center for Cancer Care in Goshen, Ind., treated its first patient with Ethos(TM) therapy, marking the first availability of this advanced cancer treatment in the state of Indiana. (PR Newswire)

September 09, 2020
Germany's first Ethos Therapy Ordered by the German Cancer Research Center

Varian (NYSE: VAR) today announced the German Cancer Research Center (DKFZ) in Heidelberg has ordered Germany's first Ethos(TM) therapy, an Adaptive Intelligence(TM) solution. This artificial intelligence (AI)-driven holistic solution is designed to...(PR Newswire)

Moore Kuehn Encourages SBPH, PFNX, VAR, and PRNB Investors to Contact Law Firm

Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately seek...(Globe Newswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.